Sekeres, MA; Gore, SD; Stablein, DM; DiFronzo, N; Abel, GA; DeZern, AE; Troy, JD; Rollison, DE; Thomas, JW; Waclawiw, MA; et al.
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.
Leukemia and Lymphoma.
2019;
60:3161-3171.
Melgar, KM; Jones, LM; Walker, M; Bolanos, LC; Hueneman, K; Wunderlich, M; Jiang, J; Wilson, K; Zhang, X; Sutter, P; et al.
Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways.
Blood.
2019;
134:3934-3934.
Barreyro, L; Sampson, A; Hueneman, K; Choi, K; Christie, S; Wang, D; Huang, G; Starczynowski, DT.
Cell-Intrinsic Inflammation Drives Progression from Myelodysplastic Syndromes to Leukemia.
Blood.
2019;
134:2983-2983.
Goll, JB; Lindsley, RC; Hooper, WF; Bejar, R; Walker, J; Fulton, R; Abel, GA; Al Baghdadi, T; Deeg, HJ; DeZern, AE; et al.
Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study.
Blood.
2019;
134:4271-4271.
Choudhary, GS; Smith, MA; Pellagatti, A; Bhagat, TD; Gordon, S; Pandey, S; Shah, N; Aluri, S; Booher, RN; Ramachandra, M; et al.
SF3B1 Mutations Induce Oncogenic IRAK4 Isoforms and Activate Targetable Innate Immune Pathways in MDS and AML.
Blood.
2019;
134:4224-4224.
Melgar, K; Walker, MM; Jones, LM; Bolanos, LC; Hueneman, K; Wunderlich, M; Jiang, J; Wilson, KM; Zhang, X; Sutter, P; et al.
Overcoming adaptive therapy resistance in AML by targeting immune response pathways.
Science Translational Medicine.
2019;
11.
Rawat, R; Starczynowski, DT; Ntziachristos, P.
Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease.
Current Opinion in Cell Biology.
2019;
58:85-94.
Smith, MA; Choudhary, GS; Pellagatti, A; Choi, K; Bolanos, LC; Bhagat, TD; Gordon-Mitchell, S; Von Ahrens, D; Pradhan, K; Steeples, V; et al.
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
Nature Cell Biology.
2019;
21:640-650.